HEPION PHARMS INC (HEPA) is a publicly traded the market company. As of July 11, 2026, HEPA trades at $0.86 with a market cap of $0 and a P/E ratio of -0.01. HEPA moved -2.06% today. Year to date, HEPA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.25 to $70.00. Rallies surfaces HEPA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HEPA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $0 |
| P/E Ratio | -0.01 |
| EPS | $-107.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $70.00 |
| 52-Week Low | $0.25 |
| Volume | 888.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.19M |
| Gross Margin | 0.00% |
HEPA analyst coverage data. Average price target: $0.00.